[ad_1]
A new blood test that evaluates four protein biomarkers dramatically improves the ability to identify the risk of lung cancer, according to the International Agency for Research on Cancer (IARC).
This method allows to identify the people who should to perform a TAC test, a radiological radiology traditionally used to diagnose this disease
One of the leading researchers in the study, Mattias Johansson , said that EFE was "the first time a blood test is used in the context of detection"
This new model takes into account the individual consumption of tobacco and analyzes blood levels of protein CA125, Pro- SFTPB, CYFRA 21-1 and CEA, some of which, like CYFRA 21 -1, is already examined individually to diagnose other cancers such as ovarian cancer 659004] The study analyzed the blood of lung cancer patients while the disease was still in the early stages of development
The new system, according to Johansson, identified among smokers and former smokers 63% of future patients, The Director of IARC, Christopher Wild, said in a press release that "smoking prevention is the best way to reduce the risk of smoking." the risk of developing lung cancer; between smokers and former high-risk smokers, early detection plays a key role in the fight against this disease. "
Lung cancer accounts for 20% of all cancer-related deaths worldwide and most of them 80-90%, are caused by smoking, confirms IARC – an entity that is part of World Health Organization (WHO)
Source: Agerpres
[ad_2]
Source link
